MELISSA SHORT: Open Payments
NPI 1578617908 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 34 payments from 6 companies in 2025. Trend: 2023 $600 · 2024 $448 · 2025 $505
Food & beverage: $423Education: $81
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 25 | $147 |
| ABBVIE INC. | 2 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Averitas Pharma Inc. | 2 | $49 |
| TG Therapeutics, Inc. | 1 | $41 |
Products named: NURTEC ODT, QULIPTA, KESIMPTA, QUTENZA, BRIUMVI.
Industry payments across MD — which companies pay providers there.
